A new Nature study suggests that the glucose–fructose blend typical of sodas and juices fuels colorectal cancer metastasis ...
The EMA’s CHMP has adopted two positive opinions for Merck’s pembrolizumab (KEYTRUDA), potentially expanding its use in ...
A large clinical trial from Karolinska Institutet shows that daily low-dose aspirin can cut colorectal cancer recurrence risk ...
In the next 25 years, climate-driven health impacts could result in the loss of more than $1.5 trillion in lost output from ...
The FDA has granted Breakthrough Therapy Designation to raludotatug deruxtecan (R-DXd), a novel antibody-drug conjugate (ADC) ...
The third-generation tyrosine kinase inhibitor olverembatinib may represent a major advance for patients with chronic myeloid leukemia and Ph+ acute lymphoblastic leukemia, especially those with ...
It was truly exciting and a great pleasure to have the opportunity to interview Susanna Greer, CSO at the V Foundation, and ...
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is ...
FDA Grants Fast Track Designation to Birelentinib for Relapsed/Refractory CLL and SLL ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback